Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Oruka Therapeutics, Inc.(ORKA) | 3,705,262 | 3,705,262 | 0 | $181.74M | $352.63M | 23.31% | +$170.89M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,537,191 | 2,537,191 | 0 | $212.92M | $247.33M | 16.35% | +$34.40M |
| Damora Therapeutics, Inc.(DMRA) | 8,713,000 | 8,713,000 | 0 | $225.67M | $226.63M | 14.98% | +$958.4K |
| Cogent Biosciences, Inc.(COGT) | 5,503,418 | 5,503,418 | 0 | $211.83M | $212.98M | 14.08% | +$1.16M |
| JADE BIOSCIENCES INC | 4,553,494 | 4,553,494 | 0 | $63.98M | $101.18M | 6.69% | +$37.20M |
| ENLIVEN THERAPEUTICS INC | 1,855,644 | 1,855,644 | 0 | $72.74M | $94.17M | 6.22% | +$21.43M |
| Viridian Therapeutics, Inc.(VRDN) | 3,914,458 | 5,090,928 | +1,176,470 | $76.57M | $93.52M | 6.18% | +$16.95M |
| Zenas BioPharma, Inc.(ZBIO) | 2,359,025 | 2,359,025 | 0 | $46.12M | $59.87M | 3.96% | +$13.75M |
| CRESCENT BIOPHARMA INC. | 2,747,866 | 2,747,866 | 0 | $50.48M | $49.46M | 3.27% | -$1.02M |
| APOGEE THERAPEUTICS INC | 298,647 | 298,647 | 0 | $25.14M | $39.64M | 2.62% | +$14.50M |
| FAETH THERAPEUTICS INC | 0 | 722,020 | +722,020 | $0 | $18.05M | 1.19% | +$18.05M |
| INHIBIKASE THERAPEUTICS INC | 8,625,000 | 8,625,000 | 0 | $14.49M | $17.51M | 1.16% | +$3.02M |
| Spyre Therapeutics, Inc.(SYRE) | 4,018,101 | 0 | -4,018,101 | $202.67M | $0 | — | -$202.67M |